phase ii trial of patritumab deruxtecan in metastatic breast cancer
Published 11 months ago • 398 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
1:52
patritumab deruxtecan in patients with egfr-mutant nsclc
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
1:39
treatment for her2 metastatic breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
0:46
what does the future hold for adcs in breast cancer?
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
2:45
paloma-3: phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
1:07
phase ii results for pembrolizumab monotherapy in metastatic tnbc
-
7:27
introduction and exploration of fulvestrant in metastatic breast cancer
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
1:39
clinical trials for stage ii-iii breast cancer
-
1:01
the metastatic breast cancer project
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
7:02
buparlisib helps overcome endocrine resistance in metastatic breast cancer: belle-2 trial results
-
4:36
phase iii clinical trials in her2-positive breast cancer
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer